[Characteristics of hepatitis and influenza antivirals: update 2009].
This article aims to review hepatitis B and C and influenza infections and to summarise the main characteristics of the antiviral drugs available to treat those infections in adults. The review of each drug focuses on dosage depending on treatment indication, dosage adjustment in renal or hepatic impairment, main pharmacokinetic features and the most significant adverse effects and drug interactions.
Lopez-Suñé
Ester
E
Servicio de Farmacia, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic Universitari, Barcelona, España. eslopez@clinic.ub.es
Tuset
Montse
M
Laguno
Montse
M
Moreno
Asunción
A
Miró
José M
JM
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D015507:Drugs, Investigational / Q000627:therapeutic use; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy
D000998:Antiviral Agents; D015507:Drugs, Investigational